COVID-19 Update

Combatting Future Viral Threats with Vaccine Advances

The COVID-19 pandemic has led to many changes in how pharmaceutical companies develop vaccines.

What’s Next for COVID-19 Vaccines and Variants?

More technologies and treatments are emerging for COVID-19—along with new variants.

Key Elements for Assay Transfer Success

Partnerships formed during the COVID-19 pandemic have provided a platform for change in assay development and transfers.

Clinical Data on Moderna COVID-19 Vaccine Published

March 04, 2021

The European Medicines Agency and Health Canada have published clinical data used to support the authorization of Moderna’s COVID-19 vaccine.

FDA Protects Consumers Against COVID-19 Scams

March 04, 2021

The agency is working to identify and obstruct scammers looking to profit from the pandemic.

FDA Publishes Guidance on Changes to COVID-19 Container Closure Systems

March 04, 2021

The guidance document provides recommendations for reporting and implementing changes to container closure system components consisting of glass vials and stoppers for sterile drug products.

Merck to Manufacture J&J Vaccine

March 03, 2021

With funding from the federal government, Merck will expand capacity to produce J&J’s COVID-19 vaccine.

Genetic Vaccine Platforms Demonstrate Their Potential

March 03, 2021

In a pandemic, genetic vaccines offer several advantages over traditional approaches.

AstraZeneca Progresses Rollout of COVID-19 Vaccine to Low- and Middle-Income Countries

March 03, 2021

AstraZeneca has announced that the mass rollout of its COVID-19 vaccine has begun via the COVAX initiative.

Slovakia Approves Sputnik V Vaccine

March 03, 2021

RDIF has announced that the Sputnik V vaccine for COVID-19 has been approved in Slovakia under the emergency use authorization procedure.

Pandemic Spurs Cybersecurity Risks in Laboratories

March 02, 2021

Pharmaceutical laboratories must work to maintain lab data integrity practices as the pandemic surges on and cybersecurity risks increase.

Demonstrating the Value of Collaboration

March 02, 2021

The rapid and efficient delivery of innovative treatments through the COVID-19 pandemic has demonstrated the value of collaborations within the bio/pharma industry.

Fighting Through This Slow Season of Change

March 02, 2021

Bio/pharma works hard today to change the calendar to tomorrow.